| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |